Everself

Everself is a company founded in 2023 headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Everself provides a one-time non-surgical endoscopic procedure to reduce stomach size for clinical obesity management, combined with a year-long concierge care program that offers continuous medical support and habit-building resources through physicians, dietitians, coaches, and a digital app.